New Zealand Markets closed

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
251.83+5.30 (+2.15%)
At close: 04:00PM EDT
250.50 -1.33 (-0.53%)
After hours: 04:53PM EDT

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800

IndustryMedical Instruments & Supplies
Full-time employees75,000

Key executives

NameTitlePayExercisedYear born
Mr. Thomas E. Polen Jr.Pres, CEO & Chairman3.69MN/A1973
Mr. Christopher DelOreficeExec. VP & CFO511.65kN/A1971
Mr. Samrat S. Khichi Esq.Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel1.46MN/A1967
Mr. Alberto MasExec. VP & Pres of the Medical Segment1.58MN/A1961
Mr. Simon D. CampionExec. VP & Pres of Interventional Segment1.31MN/A1971
Mr. Thomas J. SpoerelSr. VP, Controller & Chief Accounting OfficerN/AN/A1978
Ms. Elizabeth McCombsExec. VP & Chief Technology OfficerN/AN/A1976
Mr. Jerry FlaszExec. VP of Global Services & Chief Information OfficerN/AN/AN/A
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory BoardN/AN/AN/A
Ms. Francesca M. DeMartinoSr. VP & Head of Investor RelationsN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Corporate governance

Becton, Dickinson and Company’s ISS governance QualityScore as of 1 May 2022 is 10. The pillar scores are Audit: 8; Board: 9; Shareholder rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.